39416203|t|Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine activity in aged mice.
39416203|a|INTRODUCTION: Alzheimer's disease (AD) patients are at greater risk of focal seizures than similarly aged adults; these seizures, left untreated, may worsen functional decline. Older people with epilepsy generally respond well to antiseizure medications (ASMs). However, whether specific ASMs can differentially control seizures in AD is unknown. The corneal kindled mouse model of acquired chronic secondarily generalized focal seizures allows for precisely timed drug administration studies to quantify the efficacy and tolerability of ASMs in an AD-associated genetic model. Wh+e hypothesized that mechanistically distinct ASMs would exert differential anticonvulsant activity and tolerability in aged AD mice (8-15 months) to define whether rational ASM selection may benefit specific AD genotypes. METHODS: Aged male and female PSEN2-N141I versus age-matched non-transgenic control (PSEN2 control) C57Bl/6J mice, and APPswe/PS1dE9 versus transgene negative (APP control) littermates underwent corneal kindling to quantify latency to fully kindled criterion. Dose-related ASM efficacy was then compared in each AD model versus matched control over 1-2 months using ASMs commonly prescribed in older adults with epilepsy: valproic acid, levetiracetam, lamotrigine, phenobarbital, and gabapentin. RESULTS: Sex and AD genotype differentially impacted seizure susceptibility. Male PSEN2-N141I mice required more stimulations to attain kindling criterion (X2=5.521; p<0.05). Male APP/PS1 mice did not differ in kindling rate versus APP control mice, but they did have more severe seizures. There were significant ASM class-specific differences in acute seizure control and dose-related tolerability. APP/PS1 mice were more sensitive than APP controls to valproic acid, levetiracetam, and gabapentin. PSEN2-N141I mice were more sensitive than PSEN2 controls to valproic acid and lamotrigine. DISCUSSION: AD genotypes may differentially impact ASMs activity and tolerability in vivo with advanced biological age. These findings highlight the heterogeneity of seizure risk in AD and suggest that precisely selected ASMs may beneficially control seizures in AD, thus reducing functional decline.
39416203	0	19	Alzheimer's disease	Disease	MESH:D000544
39416203	81	88	seizure	Disease	MESH:D012640
39416203	140	144	mice	Species	10090
39416203	160	179	Alzheimer's disease	Disease	MESH:D000544
39416203	181	183	AD	Disease	MESH:D000544
39416203	185	193	patients	Species	9606
39416203	223	231	seizures	Disease	MESH:D012640
39416203	266	274	seizures	Disease	MESH:D012640
39416203	341	349	epilepsy	Disease	MESH:D004827
39416203	376	399	antiseizure medications	Chemical	-
39416203	401	405	ASMs	Chemical	-
39416203	434	438	ASMs	Chemical	-
39416203	466	474	seizures	Disease	MESH:D012640
39416203	478	480	AD	Disease	MESH:D000544
39416203	513	518	mouse	Species	10090
39416203	575	583	seizures	Disease	MESH:D012640
39416203	684	688	ASMs	Chemical	-
39416203	695	697	AD	Disease	MESH:D000544
39416203	772	776	ASMs	Chemical	-
39416203	851	853	AD	Disease	MESH:D000544
39416203	854	858	mice	Species	10090
39416203	900	903	ASM	Chemical	-
39416203	935	937	AD	Disease	MESH:D000544
39416203	979	984	PSEN2	Gene	19165
39416203	985	990	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;OriginalGene:19165;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:10090;CA#:224953
39416203	1034	1039	PSEN2	Gene	19165
39416203	1058	1062	mice	Species	10090
39416203	1222	1225	ASM	Chemical	-
39416203	1261	1263	AD	Disease	MESH:D000544
39416203	1315	1319	ASMs	Chemical	-
39416203	1361	1369	epilepsy	Disease	MESH:D004827
39416203	1371	1384	valproic acid	Chemical	MESH:D014635
39416203	1386	1399	levetiracetam	Chemical	MESH:D000077287
39416203	1401	1412	lamotrigine	Chemical	MESH:D000077213
39416203	1414	1427	phenobarbital	Chemical	MESH:D010634
39416203	1433	1443	gabapentin	Chemical	MESH:D000077206
39416203	1462	1464	AD	Disease	MESH:D000544
39416203	1498	1505	seizure	Disease	MESH:D012640
39416203	1527	1532	PSEN2	Gene	19165
39416203	1533	1538	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;OriginalGene:19165;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:10090;CA#:224953
39416203	1539	1543	mice	Species	10090
39416203	1629	1632	PS1	Gene	19164
39416203	1633	1637	mice	Species	10090
39416203	1689	1693	mice	Species	10090
39416203	1725	1733	seizures	Disease	MESH:D012640
39416203	1758	1761	ASM	Chemical	-
39416203	1798	1805	seizure	Disease	MESH:D012640
39416203	1849	1852	PS1	Gene	19164
39416203	1853	1857	mice	Species	10090
39416203	1899	1912	valproic acid	Chemical	MESH:D014635
39416203	1914	1927	levetiracetam	Chemical	MESH:D000077287
39416203	1933	1943	gabapentin	Chemical	MESH:D000077206
39416203	1945	1950	PSEN2	Gene	19165
39416203	1951	1956	N141I	ProteinMutation	tmVar:p|SUB|N|141|I;HGVS:p.N141I;VariantGroup:0;OriginalGene:19165;CorrespondingGene:5664;RS#:63750215;CorrespondingSpecies:10090;CA#:224953
39416203	1957	1961	mice	Species	10090
39416203	1987	1992	PSEN2	Gene	19165
39416203	2005	2018	valproic acid	Chemical	MESH:D014635
39416203	2023	2034	lamotrigine	Chemical	MESH:D000077213
39416203	2048	2050	AD	Disease	MESH:D000544
39416203	2087	2091	ASMs	Chemical	-
39416203	2202	2209	seizure	Disease	MESH:D012640
39416203	2218	2220	AD	Disease	MESH:D000544
39416203	2257	2261	ASMs	Chemical	-
39416203	2287	2295	seizures	Disease	MESH:D012640
39416203	2299	2301	AD	Disease	MESH:D000544
39416203	Association	MESH:D014635	RS#:63750215;HGVS:p.N141I;CorrespondingGene:5664
39416203	Negative_Correlation	MESH:D000077213	MESH:D012640
39416203	Negative_Correlation	MESH:D000077287	MESH:D012640
39416203	Association	MESH:D000077213	RS#:63750215;HGVS:p.N141I;CorrespondingGene:5664
39416203	Negative_Correlation	MESH:D000077206	MESH:D004827
39416203	Association	MESH:D014635	19165
39416203	Negative_Correlation	MESH:D014635	MESH:D012640
39416203	Negative_Correlation	MESH:D010634	MESH:D004827
39416203	Negative_Correlation	MESH:D000077287	MESH:D004827
39416203	Negative_Correlation	MESH:D010634	MESH:D012640
39416203	Negative_Correlation	MESH:D000077206	MESH:D012640
39416203	Negative_Correlation	MESH:D014635	MESH:D004827
39416203	Negative_Correlation	MESH:D000077213	MESH:D004827
39416203	Association	MESH:D000077213	19165

